UBS Starts Kemet (KEM) at Neutral; Restructuring Yields Benefits but Normalized Model Unclear

April 5, 2011 10:40 AM EDT Send to a Friend
UBS initiates coverage on Kemet (NYSE: KEM) with a Neutral. PT $16.

UBS analyst says, "KEM is a manufacturer of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login